Zyga gets 510(k) clearance; Study finds information sharing needed when it comes to organ transplants;

@FierceMedDev: Roche shells out up to $425M for superbug testing outfit. FierceDiagnostics news | Follow @FierceMedDev

@VarunSaxena2: ICYMI: Google joins forces with Dexcom for miniaturized glucose monitor. Article | Follow @VarunSaxena2

@EmilyWFierce: NICE plots takeover of England's Cancer Drugs Fund. FiercePharma article | Follow @EmilyWFierce

> Zyga Technologies received a 510(k) clearance from the FDA for its SImmetry System to treat lumbar spine conditions. More

> A study found that there is a need to increase the sharing of information between organ donors and their recipients. More

Biotech News

@FierceBiotech: FierceBiotech Radio on Amarin's First Amendment crusade, Martin Shkreli's Twitter, and Kim Kardashian's Instagram. Listen/Subscribe | Follow @FierceBiotech

@JohnCFierce: California cutbacks: Boston Sci to close two facilities, Abbott cuts 160+ employees. FierceMedicalDevices article | Follow @JohnCFierce

@DamianFierce: ICYMI: A wonderfully stern FDA official parses Kim Kardashian's Instagram. Letter | Follow @DamianFierce

> KemPharm spikes as its anti-abuse pain drug rolls toward the FDA. Story

> Lilly's CEO keeps faith in the pipeline as biotech gets 'too expensive.' Article

> CRO giant WuXi is going private in a $3.3B deal. News

> Avalanche hits the brakes on its gene therapy program after a Phase II misstep. Report

Pharma News

@FiercePharma: China FDA issues software guidelines on medical devices effective this month. FiercePharmaAsia story | Follow @FiercePharma

@EricPFierce: Sun U.S. sales gut-kicked by supply constraints as it works on FDA concerns at Halol plant. More from FiercePharmaManufacturing | Follow @EricPFierce

@CarlyHFierce: Biogen touts new Eloctate data as next-gen hemophilia rivals near the scene. FiercePharmaMarketing article | Follow @CarlyHFierce

> Novo says new U.S. plant may be best bet to offset the FX bite. More

> Shire raise its $30B Baxalta bid? It's going to need some details first. Article

> Takeda Actos settlement seems shaky as plaintiffs give it the sniff test. Story

> NICE plots takeover of England's Cancer Drugs Fund. Report

Sponsored By Paraza Pharma

Choosing the Right Pre-Clinical Collaborative Research Organization (CRO)

Learn about the key factors that are essential to creating a collaborative and productive working relationship to advance pre-clinical drug discovery programs.